(Q44029564)

29 November 2017

title

Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapies (English)

1 reference

29 November 2017

1 reference

1 reference

Robert A Reiss

1

1 reference

29 November 2017

Curtis E Haas

2

1 reference

29 November 2017

Deborah L Griffis

3

1 reference

29 November 2017

Bernadette Porter

4

1 reference

29 November 2017

Mary Ann Tara

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

22

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

677-685

1 reference

Clinical utilization of the international normalized ratio (INR).

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Status of point-of-care testing: promise, realities, and possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Oral Anticoagulation Monitoring Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Comparing methods of measurement: why plotting difference against standard method is misleading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Heparin-induced increase in the international normalized ratio. Responses of 10 commercial thromboplastin reagents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Risk factors for intracranial hemorrhage in outpatients taking warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Problems in laboratory monitoring of heparin dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

Measurement in Medicine: The Analysis of Method Comparison Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.677.34060

10.1592/PHCO.22.9.677.34060

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference